-
US FDA inspects Lupin’s Tarapur API facility
financialexpress
September 04, 2018
Rules out presence of NDMA impurity in co’s Valsartan, Losartan and Irbesartan APIs
-
A Glimpse of Influences of Tariff Slapping on the Chinese Pharmaceutical Industry at the Sensitive Time of Sino-U.S. Trade Friction
Xiaoyaowan
April 23, 2018
News about the trade war between the U.S. and China recently has been stirring the market nerves.
-
Sterling Pharma Invests £6M To Expand Offerings
contractpharma
April 20, 2018
Sterling Pharma Solutions, a CDMO, is investing £6m into its pilot plant facility at its UK site to enhance its scale-up and small to midscale commercial API manufacturing capabilities.
-
Hovione divestment marks its commitment to supplying highly specialized APIs
cphi-online
March 12, 2018
Portuguese company exits the large volume business of contrast media to concentrate on its CDMO business.
-
FDA warns API maker Daito Kasei Kogyo, bans some products
fiercepharma
February 05, 2018
An API maker in Osaka, Japan, whose slogan is "Happiness, Awe and Surprise" has joined a growing list of Japanese drugmakers to be criticized by the FDA in warning letters.
-
Winter is Coming! —Events of the Chinese API Industry in 2017
Caicai
January 12, 2018
Winter is Coming! This line of the Game of Thrones well-known in the world may be used to best describe the current situation of the Chinese API industry.
-
End of the Era of API Approval Numbers! DMF Filing System Starting to be Implemented Formally
Caicai
December 27, 2017
Do you know how diligent this administration of CFDA is?
-
Perrigo Secures API Divestiture for $110M
contractpharm
November 22, 2017
Perrigo has completed its $ 110 million divestment of its API business in Israel
-
Sterling Expands API Capabilities
contractpharma
October 25, 2017
nvests £6 million to strengthen and expand its milling, micronization and solid form capabilities
-
Piramal Pharma Solutions invests US$55 million into API manufacturing facilities expansion
pharmaasia
October 20, 2017
Piramal Pharma's latest large scale expansion targets the capacity boosting of its API manufacturing sites across North America and Asia.